학술논문

JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer
Document Type
Journal
Source
CANCER; SEP 3 2021, 10p.
Subject
Language
English
ISSN
10970142